EFAVIRENZ, ATAZANAVIR, AND RITONAVIR DISRUPT SARCOPLASMIC RETICULUM Ca2+ HOMEOSTASIS IN SKELETAL MUSCLES.

[1]  L. M. Espinoza-Fonseca,et al.  Linking Biochemical and Structural States of SERCA: Achievements, Challenges, and New Opportunities , 2020, International journal of molecular sciences.

[2]  J. Falutz.  Frailty in People Living with HIV , 2020, Current HIV/AIDS Reports.

[3]  P. Allen,et al.  TRPCs: Influential Mediators in Skeletal Muscle , 2020, Cells.

[4]  P. Cinque,et al.  The Role of Physical Activity for the Management of Sarcopenia in People Living with HIV , 2020, International journal of environmental research and public health.

[5]  Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV , 2020 .

[6]  J. Margolick,et al.  Aging, sex, inflammation, frailty, and CMV and HIV infections. , 2019, Cellular immunology.

[7]  A. Justice,et al.  Strengths and Limitations of the Veterans Aging Cohort Study Index as a Measure of Physiologic Frailty. , 2019, AIDS research and human retroviruses.

[8]  K. O’Brien,et al.  Functional Limitations and Disability in Persons Living with HIV in South Africa and United States: Similarities and Differences , 2019, Journal of the International Association of Providers of AIDS Care.

[9]  L. Chiche,et al.  Frailty phenotype in older people living with HIV: concepts, prevention and issues. , 2019, Geriatrie et psychologie neuropsychiatrie du vieillissement.

[10]  M. Bloch.  Frailty in people living with HIV , 2018, AIDS Research and Therapy.

[11]  A. Richardson,et al.  Oxidative stress‐induced dysregulation of excitation–contraction coupling contributes to muscle weakness , 2018, Journal of cachexia, sarcopenia and muscle.

[12]  G. Suryakumar,et al.  Role of defective Ca2+ signaling in skeletal muscle weakness: Pharmacological implications , 2018, Journal of Cell Communication and Signaling.

[13]  D. Laver.  Regulation of the RyR channel gating by Ca2+ and Mg2+ , 2018, Biophysical Reviews.

[14]  G. Ávila.  Disturbed Ca2+ Homeostasis in Muscle-Wasting Disorders. , 2018, Advances in experimental medicine and biology.

[15]  M. Sánchez-Conde,et al.  [HIV infection as a cause of accelerated aging and frailty]. , 2018, Revista espanola de geriatria y gerontologia.

[16]  J. Margolick,et al.  Frailty and subclinical coronary atherosclerosis: The Multicenter AIDS Cohort Study (MACS). , 2017, Atherosclerosis.

[17]  C. Schwartz,et al.  Association of FK506 binding proteins with RyR channels – effect of CLIC2 binding on sub-conductance opening and FKBP binding , 2017, Journal of Cell Science.

[18]  J. Margolick,et al.  Geriatric syndromes: new frontiers in HIV and sarcopenia , 2017, AIDS.

[19]  M. Rizzo,et al.  Interactions between small ankyrin 1 and sarcolipin coordinately regulate activity of the sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA1) , 2017, The Journal of Biological Chemistry.

[20]  J. Margolick,et al.  Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men with or at Risk for HIV , 2016, The Journal of infectious diseases.

[21]  L. Thompson,et al.  Age-induced oxidative stress: how does it influence skeletal muscle quantity and quality? , 2016, Journal of applied physiology.

[22]  S. Jaber,et al.  Leaky ryanodine receptors contribute to diaphragmatic weakness during mechanical ventilation , 2016, Proceedings of the National Academy of Sciences.

[23]  R. Lovering,et al.  Critical Role of Intracellular RyR1 Calcium Release Channels in Skeletal Muscle Function and Disease , 2016, Front. Physiol..

[24]  T. Duhamel,et al.  The regulation of sarco(endo)plasmic reticulum calcium-ATPases (SERCA). , 2015, Canadian journal of physiology and pharmacology.

[25]  S. Kutty,et al.  CCDI: a new ligand that modulates mammalian type 1 ryanodine receptor (RyR1) , 2014, British journal of pharmacology.

[26]  David S. Rubin,et al.  High Prevalence of Low Skeletal Muscle Mass Associated with Male Gender in Midlife and Older HIV-Infected Persons Despite CD4 Cell Reconstitution and Viral Suppression , 2014, Journal of the International Association of Providers of AIDS Care.

[27]  S. Rajbhandari,et al.  FMLP-, thapsigargin-, and H2O2-evoked changes in intracellular free calcium concentration in lymphocytes and neutrophils of type 2 diabetic patients , 2013, Molecular and Cellular Biochemistry.

[28]  J. Esplugues,et al.  ER stress in human hepatic cells treated with Efavirenz: mitochondria again. , 2013, Journal of hepatology.

[29]  S. Bhasin,et al.  Lopinavir/Ritonavir Impairs Physical Strength in Association with Reduced Igf1 Expression in Skeletal Muscle of Older Mice , 2013, Journal of AIDS & clinical research.

[30]  Rajender K. Motiani,et al.  What Role for Store‐Operated Ca2+ Entry in Muscle? , 2013, Microcirculation.

[31]  S. Kutty,et al.  Carbonylation Induces Heterogeneity in Cardiac Ryanodine Receptor Function in Diabetes Mellitus , 2012, Molecular Pharmacology.

[32]  S. Gemma,et al.  The Ca2+-ATPase (SERCA1) Is Inhibited by 4-Aminoquinoline Derivatives through Interference with Catalytic Activation by Ca2+, Whereas the ATPase E2 State Remains Functional* , 2011, The Journal of Biological Chemistry.

[33]  T. Shiomi,et al.  Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. , 2011, Cell metabolism.

[34]  S. Kutty,et al.  Gain of function of cardiac ryanodine receptor in a rat model of type 1 diabetes. , 2011, Cardiovascular research.

[35]  D. Katzenstein,et al.  Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1 , 2011, Annals of Internal Medicine.

[36]  R. Kronmal,et al.  Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[37]  Mu Wang,et al.  Carbonylation Contributes to SERCA2a Activity Loss and Diastolic Dysfunction in a Rat Model of Type 1 Diabetes , 2011, Diabetes.

[38]  Stuart M Phillips,et al.  Resistance exercise and appropriate nutrition to counteract muscle wasting and promote muscle hypertrophy , 2010, Current opinion in clinical nutrition and metabolic care.

[39]  D. Romberger,et al.  Chloroform extract of hog barn dust modulates skeletal muscle ryanodine receptor calcium-release channel (RyR1). , 2010, Journal of applied physiology.

[40]  Jian Xiao,et al.  Berberine Inhibits HIV Protease Inhibitor-Induced Inflammatory Response by Modulating ER Stress Signaling Pathways in Murine Macrophages , 2010, PloS one.

[41]  Anuradha Kalyanasundaram,et al.  SERCA pump isoforms: Their role in calcium transport and disease , 2007, Muscle & nerve.

[42]  P. Hylemon,et al.  HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[43]  Sergio L. Schmukler,et al.  Emerging Market Instability : Do Sovereign Ratings Affect Country Risk and Stock Returns ? , 1997 .

[44]  A. E. Rossi,et al.  Sarcoplasmic reticulum: The dynamic calcium governor of muscle , 2006, Muscle & nerve.

[45]  F. Henao,et al.  Store-operated calcium entry in differentiated C2C12 skeletal muscle cells. , 2005, Biochimica et biophysica acta.

[46]  R. Germinario,et al.  Antiretroviral protease inhibitors prevent l6 muscle cell fusion by reducing calpain activity. , 2004, AIDS research and human retroviruses.

[47]  K. Yarasheski,et al.  Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection. , 2004, AIDS research and human retroviruses.

[48]  A. de Haan,et al.  Calcium regulation and muscle disease , 2004, Journal of Muscle Research & Cell Motility.

[49]  G. Meissner,et al.  Diketopyridylryanodine Has Three Concentration-dependent Effects on the Cardiac Calcium-release Channel/Ryanodine Receptor* , 2003, The Journal of Biological Chemistry.

[50]  Vimalkumar A. Patel,et al.  Tectoridins modulate skeletal and cardiac muscle sarcoplasmic reticulum calcium-release channels. , 2000, The Journal of pharmacology and experimental therapeutics.

[51]  S. Marx,et al.  Coupled gating between individual skeletal muscle Ca2+ release channels (ryanodine receptors) , 1998, Science.

[52]  P. Junankar,et al.  Subconductance states in single-channel activity of skeletal muscle ryanodine receptors after removal of FKBP12. , 1997, Biophysical journal.

[53]  R. Humerickhouse,et al.  High affinity C10-Oeq ester derivatives of ryanodine. Activator-selective agonists of the sarcoplasmic reticulum calcium release channel. , 1994, The Journal of biological chemistry.

[54]  K. Bidasee,et al.  Dual effect of suramin on calcium fluxes across sarcoplasmic reticulum vesicle membranes. , 1994, The Journal of pharmacology and experimental therapeutics.

[55]  H. Erdjument-Bromage,et al.  FK506 binding protein associated with the calcium release channel (ryanodine receptor). , 1992, The Journal of biological chemistry.

[56]  O. Stalheim.  Major Infectious Diseases , 1991, Handbook of Animal Science.

[57]  C. J. Duncan,et al.  Sarcolemma blebs and cell damage in mammalian skeletal muscle. , 1989, Tissue & cell.

[58]  P. A. Lanzetta,et al.  An improved assay for nanomole amounts of inorganic phosphate. , 1979, Analytical biochemistry.

[59]  M. Prentki,et al.  Actin microfilaments, cell shape, and secretory processes in isolated rat hepatocytes. Effect of phalloidin and cytochalasin D , 1979, The Journal of cell biology.